Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells.
D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects*; D001241:Aspirin / Q000494:pharmacology*; D002460:Cell Line; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D008214:Lymphocytes / Q000276:immunology; D009374:Neoplasms, Experimental; D011448:Prostaglandin Antagonists; D013844:Thiazoles / Q000494:pharmacology*; D013997:Time Factors
D011448:Prostaglandin Antagonists; D013844:Thiazoles; D001241:Aspirin; D007213:Indomethacin